Trientine hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-017321
The hydrochloride salt form of a metal chelating agent with potential anti-angiogenic activity. Trientine chelates excess copper (Cu) ions in the body; the excess copper is subsequently removed from the body through the kidneys. As Cu is an essential cofactor for cuproenzymes, such as superoxide dismutase 1 (SOD1), depletion of copper may inhibit the activation of signal transduction pathways required for cellular proliferation and angiogenesis. In addition, trientine may inhibit copper-induced secretion of interleukin-8 (IL-8).
| Identifier | MLC-T-ONC-017321 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | TETA |
| Synonyms | triethylenetetramine dihydrochloride |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017321",
"term": "Trientine hydrochloride",
"field": "Oncology and biomedicine",
"definition": "The hydrochloride salt form of a metal chelating agent with potential anti-angiogenic activity. Trientine chelates excess copper (Cu) ions in the body; the excess copper is subsequently removed from the body through the kidneys. As Cu is an essential cofactor for cuproenzymes, such as superoxide dismutase 1 (SOD1), depletion of copper may inhibit the activation of signal transduction pathways required for cellular proliferation and angiogenesis. In addition, trientine may inhibit copper-induced secretion of interleukin-8 (IL-8).",
"abbreviation": "TETA",
"synonyms": [
"triethylenetetramine dihydrochloride"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/trientine-hydrochloride/"
}
Record 16,709 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.